These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21864080)

  • 1. Prodomains regulate the synthesis, extracellular localisation and activity of TGF-β superfamily ligands.
    Harrison CA; Al-Musawi SL; Walton KL
    Growth Factors; 2011 Oct; 29(5):174-86. PubMed ID: 21864080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prodomains of transforming growth factor beta (TGFbeta) superfamily members specify different functions: extracellular matrix interactions and growth factor bioavailability.
    Sengle G; Ono RN; Sasaki T; Sakai LY
    J Biol Chem; 2011 Feb; 286(7):5087-99. PubMed ID: 21135108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into the mechanisms of activin action and inhibition.
    Walton KL; Makanji Y; Harrison CA
    Mol Cell Endocrinol; 2012 Aug; 359(1-2):2-12. PubMed ID: 21763751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of bone morphogenetic protein growth factor complexes to fibrillin.
    Sengle G; Charbonneau NL; Ono RN; Sasaki T; Alvarez J; Keene DR; Bächinger HP; Sakai LY
    J Biol Chem; 2008 May; 283(20):13874-88. PubMed ID: 18339631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prodomain of BMP-7 targets the BMP-7 complex to the extracellular matrix.
    Gregory KE; Ono RN; Charbonneau NL; Kuo CL; Keene DR; Bächinger HP; Sakai LY
    J Biol Chem; 2005 Jul; 280(30):27970-80. PubMed ID: 15929982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of novel activin-targeted therapeutics.
    Chen JL; Walton KL; Al-Musawi SL; Kelly EK; Qian H; La M; Lu L; Lovrecz G; Ziemann M; Lazarus R; El-Osta A; Gregorevic P; Harrison CA
    Mol Ther; 2015 Mar; 23(3):434-44. PubMed ID: 25399825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of bone morphogenetic protein 9 procomplex.
    Mi LZ; Brown CT; Gao Y; Tian Y; Le VQ; Walz T; Springer TA
    Proc Natl Acad Sci U S A; 2015 Mar; 112(12):3710-5. PubMed ID: 25751889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of the Prodomain α1-Helix Correlates with Latency in the Transforming Growth Factor-β Family.
    Le VQ; Iacob RE; Zhao B; Su Y; Tian Y; Toohey C; Engen JR; Springer TA
    J Mol Biol; 2022 Mar; 434(5):167439. PubMed ID: 34990654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GDF11 forms a bone morphogenetic protein 1-activated latent complex that can modulate nerve growth factor-induced differentiation of PC12 cells.
    Ge G; Hopkins DR; Ho WB; Greenspan DS
    Mol Cell Biol; 2005 Jul; 25(14):5846-58. PubMed ID: 15988002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. You're going to need a bigger (glass bottom) boat.
    Peterson AJ; O'Connor MB
    Sci Signal; 2012 Apr; 5(218):pe14. PubMed ID: 22472647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structural basis of TGF-beta, bone morphogenetic protein, and activin ligand binding.
    Lin SJ; Lerch TF; Cook RW; Jardetzky TS; Woodruff TK
    Reproduction; 2006 Aug; 132(2):179-90. PubMed ID: 16885528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Inhibitory Core of the Myostatin Prodomain: Its Interaction with Both Type I and II Membrane Receptors, and Potential to Treat Muscle Atrophy.
    Ohsawa Y; Takayama K; Nishimatsu S; Okada T; Fujino M; Fukai Y; Murakami T; Hagiwara H; Itoh F; Tsuchida K; Hayashi Y; Sunada Y
    PLoS One; 2015; 10(7):e0133713. PubMed ID: 26226340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Confocal microscopy demonstrates association of LTBP-2 in fibrillin-1 microfibrils and colocalisation with perlecan in the disc cell pericellular matrix.
    Hayes AJ; Gibson MA; Shu C; Melrose J
    Tissue Cell; 2014 Jun; 46(3):185-97. PubMed ID: 24867584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of transforming growth factor-beta1, activin A, and their receptors in thyroid follicle cells: negative regulation of thyrocyte growth and function.
    Franzén A; Piek E; Westermark B; ten Dijke P; Heldin NE
    Endocrinology; 1999 Sep; 140(9):4300-10. PubMed ID: 10465304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of TGF-beta signalling by the pseudoreceptor BAMBI.
    Onichtchouk D; Chen YG; Dosch R; Gawantka V; Delius H; Massagué J; Niehrs C
    Nature; 1999 Sep; 401(6752):480-5. PubMed ID: 10519551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin, Heparan Sulphate and the TGF-β Cytokine Superfamily.
    Rider CC; Mulloy B
    Molecules; 2017 Apr; 22(5):. PubMed ID: 28468283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of transforming growth factor-beta1 and its latent form binding protein in pseudoexfoliation syndrome.
    Schlötzer-Schrehardt U; Zenkel M; Küchle M; Sakai LY; Naumann GO
    Exp Eye Res; 2001 Dec; 73(6):765-80. PubMed ID: 11846508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LTBP-2 competes with tropoelastin for binding to fibulin-5 and heparin, and is a negative modulator of elastinogenesis.
    Sideek MA; Menz C; Parsi MK; Gibson MA
    Matrix Biol; 2014 Feb; 34():114-23. PubMed ID: 24148803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A molecular recognition paradigm: promiscuity associated with the ligand-receptor interactions of the activin members of the TGF-beta superfamily.
    Keah HH; Hearn MT
    J Mol Recognit; 2005; 18(5):385-403. PubMed ID: 15948132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibin Biosynthesis and Activity Are Limited by a Prodomain-Derived Peptide.
    Walton KL; Kelly EK; Chan KL; Harrison CA; Robertson DM
    Endocrinology; 2015 Aug; 156(8):3047-57. PubMed ID: 25961838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.